PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms
Xiaolan Li(Jiangsu University), Wee Joo Chng(National University of Singapore)
Cited by 50
Related Papers
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
|The Lancet Oncology|2021|266
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
|Blood|2011|212
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
|Journal of Hematology & Oncology|2017|75